Discordance between hormone receptor profile of primary breast cancer and metastatic bone disease: should bone marrow biopsy be considered a standard of care?

被引：0
|
作者：
Amir, E. [1 ]
Broom, R. [1 ]
Freedman, O. [1 ]
Ooi, W. S. [1 ]
Done, S. [2 ]
Gianfelice, D. [3 ]
Barth, D. [1 ]
Kahn, H. [4 ]
Clemons, M. [1 ]
机构：
[1] Princess Margaret Hosp, Div Hematol & Med Oncol, Toronto, ON M4X 1K9, Canada
[2] Univ Hlth Network, Dept Pathol, Toronto, ON, Canada
[3] Univ Hlth Network, Dept Intervent Radiol, Toronto, ON, Canada
[4] Sunnybrook Med Ctr, Dept Pathol, Toronto, ON, Canada
来源：
BREAST CANCER RESEARCH | 2009年 / 11卷
关键词：
Breast Cancer; Estrogen Receptor; Progesterone Receptor; Bone Metastasis; Receptor Status;
D O I：
10.1186/bcr2310
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S18 / S18
页数：1
相关论文
共 50 条
  • [1] Discordance between hormone receptor profile of primary breast cancer and metastatic bone disease: should bone marrow biopsy be considered a standard of care?
    E Amir
    R Broom
    O Freedman
    WS Ooi
    S Done
    D Gianfelice
    D Barth
    H Kahn
    M Clemons
    Breast Cancer Research, 11
  • [2] Biomarker discordance between primary breast cancer and bone or bone marrow metastases
    Yuda, Sayako
    Shimizu, Chikako
    Yoshida, Masayuki
    Shiino, Sho
    Kinoshita, Takayuki
    Maeshima, Akiko Miyagi
    Tamura, Kenji
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2019, 49 (05) : 426 - 430
  • [3] Discordance between Receptor Status in Primary and Metastatic Breast Cancer: an Exploratory Study of Bone and Bone Marrow Biopsies
    Amir, E.
    Ooi, W. S.
    Simmons, C.
    Kahn, H.
    Christakis, M.
    Popovic, S.
    Kalina, M.
    Chesney, A.
    Singh, G.
    Clemons, M.
    CLINICAL ONCOLOGY, 2008, 20 (10) : 763 - 768
  • [4] Incidence and prognostic significance of receptor discordance between primary breast cancer and paired bone metastases
    Lin, Mingxi
    Jin, Yizi
    Lv, Hong
    Hu, Xichun
    Zhang, Jian
    INTERNATIONAL JOURNAL OF CANCER, 2023, 152 (07) : 1476 - 1489
  • [5] Comparative study of receptor discordance between primary and corresponding metastatic lesions in breast cancer
    Erdem, Gokmen U.
    Altundag, Kadri
    Ozdemir, Nuriye Y.
    Sahin, Suleyman
    Demirci, Nebi S.
    Karatas, Fatih
    Bozkaya, Yakup
    Aytekin, Aydin
    Tasdemir, Vildan
    Aslan, Alma C.
    Sever, Ali R.
    Zengin, Nurullah
    JOURNAL OF BUON, 2017, 22 (02): : 365 - 376
  • [6] Receptor Discordance in Metastatic Breast Cancer; a review of clinical and genetic subtype alterations from primary to metastatic disease
    Dowling, Gavin P.
    Keelan, Stephen
    Cosgrove, Nicola S.
    Daly, Gordon R.
    Giblin, Katie
    Toomey, Sinead
    Hennessy, Bryan T.
    Hill, Arnold D. K.
    BREAST CANCER RESEARCH AND TREATMENT, 2024, 207 (03) : 471 - 476
  • [7] Profile and Outcome of Supraclavicular Metastases in Patients with Metastatic Breast Cancer: Discordance of Receptor Status Between Primary and Metastatic Site
    Thangarajah, Fabinshy
    Vogel, Constanze
    Pahmeyer, Caroline
    Eichler, Christian
    Holtschmidt, Johannes
    Ratiu, Dominik
    Mallmann, Peter
    Malter, Wolfram
    ANTICANCER RESEARCH, 2018, 38 (10) : 6023 - 6026
  • [8] Determination and clinical significance of bone pseudoprogression in hormone receptor-positive metastatic breast cancer
    Lin, Mingxi
    Jin, Yizi
    Yang, Ziyi
    Hu, Xichun
    Zhang, Jian
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13
  • [9] Discordance in receptor status between primary and metastatic breast cancer and overall survival: A single-center analysis
    Mellouli, Manel
    Graja, Soumaya
    Ben Kridis, Wala
    Ben Ayed, Houda
    Makni, Saadia
    Triki, Meriam
    Charfi, Slim
    Khanfir, Afef
    Boudawara, Tahya Sellami
    Kallel, Rim
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2022, 61
  • [10] Prognostic Impact of Discordance in Hormone Receptor Status Between Primary and Recurrent Sites in Patients With Recurrent Breast Cancer
    Shiino, Sho
    Kinoshita, Takayuki
    Yoshida, Masayuki
    Jimbo, Kenjiro
    Asaga, Sota
    Takayama, Shin
    Tsuda, Hitoshi
    CLINICAL BREAST CANCER, 2016, 16 (04) : E133 - E140
12345